Association of Acceptability of the Bethesda System for Thyroid Fine Needle Aspiration Cytology Reporting and Professional Experience of a Cytopathologist
Keywords:
The Bethesda system, Thyroid, Fine Needle Aspiration Cytology.Abstract
Background: Fine needle aspiration cytology is commonly employed as the initial screening test for thyroid swellings. The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) in 2007 gave a uniform reporting system which aided the clinician in further management of
patients. Since its inception, TBSRTC is progressively gaining acceptance among cytopathologists. In this study, we aimed to assess the acceptability of TBSRTC and to find the association between the acceptability of TBSRTC reporting and the experience of the cytopathologist.
Material Methods: Details of thyroid FNAC reporting for 12 months (Jan 2019 to Dec 2019) were analysed. Age, gender, side of swelling as well experience of cytopathologist (<= or > 3 years) was noted. The proportion of cases reported according to TBSRTC was calculated. The association between the experience of the consultant and cytopathology reporting using TBSRTC was calculated using the Chi-square test.
Results: A total of 225 cases were reported over a period of 12 months. All the consultants used TBSRTC for reporting thyroid cytopathology however to a variable extent. Out of 70 cases reported by experienced consultants, 2.9% were not reported by TBSRTC. Consultants with 3 years or less experience reported 155 cases, out of which 17.42% were conventional. There was a statistically significant association (p=0.005) between reporting according to TBS and the experience of the consultant.
Conclusion: Cytopathologists report thyroid FNA using TBSRTC, however junior consultants may not be reporting all the cases according to TBSRTC. This may be due to a lack of experience in order to commit a case to a particular category of TBSRTC.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Author's
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.
